Today: 7 April 2026
Browse Category

Earnings Reports 26 January 2026

Amphenol stock price jumps as APH heads into Q4 earnings and a Fed-packed week

Amphenol stock price jumps as APH heads into Q4 earnings and a Fed-packed week

Amphenol shares rose 3% to close at $155.53 on Monday, outpacing the S&P 500 ahead of its fourth-quarter earnings release set for Wednesday. The move follows the company’s recent $4.1 billion acquisition of CommScope’s Connectivity and Cable Solutions business. Investors are also watching for the Federal Reserve’s rate decision on Jan. 28.
Arista Networks stock jumps 5% as traders eye Fed week and Feb. 12 earnings

Arista Networks stock jumps 5% as traders eye Fed week and Feb. 12 earnings

Arista Networks shares rose 5.4% to $143.70 Monday, nearing last week’s high amid renewed tech buying ahead of major earnings and a Federal Reserve decision. Options activity and anticipation of Arista’s Feb. 12 earnings report drove trading. Investors are watching for 2026 demand signals and updates on AI-related orders. U.S. stocks edged higher as traders weighed megacap and AI names.
Starbucks stock slips as SBUX nears earnings and Investor Day — what traders are watching

Starbucks stock slips as SBUX nears earnings and Investor Day — what traders are watching

Starbucks shares fell 1.4% to $96.22 Monday, trailing a broader market rally ahead of its fiscal Q1 earnings report Wednesday and Investor Day Thursday. Volume reached 8.1 million shares. Analysts cited steady sales but ongoing margin pressures from higher coffee and labor costs. Peers traded mixed, with McDonald’s up 1.1% and Dutch Bros down 2.8%.
Cloudflare stock jumps on viral ‘Clawdbot’ AI-agent buzz as Wall Street eyes Feb. 10 earnings

Cloudflare stock jumps on viral ‘Clawdbot’ AI-agent buzz as Wall Street eyes Feb. 10 earnings

Cloudflare shares surged 11.5% to $193.30 Monday, outpacing sector rivals after social media buzz around “Clawdbot,” an open-source AI agent built on Anthropic’s Claude. Wolfe Research linked the rally to expectations that Cloudflare’s network could benefit if AI-driven traffic rises. Investors await Cloudflare’s Feb. 10 earnings and the Federal Reserve’s policy decision this week. Akamai, Fastly, and Zscaler also posted gains.
Pfizer stock edges up as traders brace for Feb. 3 earnings and a Fed decision

Pfizer stock edges up as traders brace for Feb. 3 earnings and a Fed decision

Pfizer shares rose 0.7% to $25.84 in Monday afternoon trading, tracking a broader U.S. stock rally ahead of major earnings and a Federal Reserve policy decision. Investors are watching for Pfizer’s Feb. 3 earnings and updates on its 2026 outlook, as the company faces falling COVID demand and looming patent expirations. Trading volume remained moderate, with no major company news released.
Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings

Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings

Boston Scientific shares rose 1.7% to $94.12 Monday, outpacing medical-device peers and the S&P 500. Evercore reaffirmed its Outperform rating and $112 target, dismissing concerns about the $14.5 billion Penumbra acquisition. Investors await the Feb. 4 earnings call for updates on integration, financing, and demand trends. The Penumbra deal is expected to close in 2026.
Texas Instruments stock price rises ahead of Q4 earnings — what could move TXN next

Texas Instruments stock price rises ahead of Q4 earnings — what could move TXN next

Texas Instruments shares rose 1.5% to $196.20 Monday, outpacing a flat semiconductor sector ahead of its quarterly earnings report due Tuesday after markets close. Analysts expect EPS of $1.29 on $4.44 billion revenue. CEO Haviv Ilan and CFO Rafael Lizardi will lead the earnings call at 3:30 p.m. Central. Investors are watching for signs of recovery in industrial and automotive chip demand.
AbbVie stock price edges up: what investors watch ahead of Feb. 4 earnings

AbbVie stock price edges up: what investors watch ahead of Feb. 4 earnings

AbbVie shares rose 0.4% to $220.10 Monday, moving between $217.15 and $221.48 as investors awaited its Feb. 4 earnings report. Health-care stocks held firm, with the sector ETF up 0.4% and Johnson & Johnson and Pfizer also gaining. AbbVie’s upcoming results will highlight its immunology drugs as it faces pressure from declining Humira sales and recent policy deals. Traders are watching Wednesday’s Fed decision before the earnings release.
GE Vernova stock price rises as Morgan Stanley trims target ahead of earnings

GE Vernova stock price rises as Morgan Stanley trims target ahead of earnings

GE Vernova shares rose 1.7% to $669.04 Monday afternoon ahead of its quarterly earnings report, due before markets open Jan. 28. Morgan Stanley maintained an Overweight rating but lowered its price target to $817. Wall Street expects earnings of $3.03 per share on $10.04 billion revenue. The report coincides with the Federal Reserve’s policy decision Wednesday.
Caterpillar stock climbs in New York as CAT traders brace for earnings, Fed week

Caterpillar stock climbs in New York as CAT traders brace for earnings, Fed week

Caterpillar shares rose 1.7% to $637.22 Monday, with 1.3 million shares traded ahead of its Jan. 29 earnings report. Analysts expect higher revenue but lower profit, projecting $4.67 per share on $17.89 billion. Options pricing signals a possible 6% move after results. The Federal Reserve’s Jan. 27-28 meeting and ongoing tariffs add uncertainty for machinery stocks.
Coca-Cola stock price barely moves today as Fed week and earnings loom

Coca-Cola stock price barely moves today as Fed week and earnings loom

Coca-Cola shares slipped 0.1% to $72.83 Monday afternoon as investors awaited the Federal Reserve’s Jan. 27-28 policy decision. The broader consumer staples sector also declined, while PepsiCo rose 0.7%. Coca-Cola will report fourth-quarter and full-year results on Feb. 10. The company recently announced leadership changes, including a new chief digital officer.
1 75 76 77 78 79 229

Stock Market Today

  • Vivid Electromech Shares List at 2% Premium on NSE SME, Rally Extends to 5% Upper Band
    April 7, 2026, 3:07 AM EDT. Vivid Electromech's shares debuted on the NSE SME platform at ₹565, a 2% premium over the ₹555 IPO price, defying a nil grey market premium before listing. The stock later surged to the 5% upper price band of ₹593.25. The company's ₹130.54 crore IPO, combining fresh equity and offer for sale, raised ₹37.12 crore from anchor investors. Subscription was modest at 1.06 times overall, with retail demand notably weak at 36%. Vivid Electromech manufactures low-voltage and medium-voltage electrical panels for industrial automation. Proceeds will fund a new manufacturing unit, debt repayment, and working capital. Hem Securities led the issue, with MUFG Intime India as registrar.
Go toTop